Llwytho...
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity
Liraglutide is a long-acting human glucagon-like peptide-1 (GLP-1) analogue and an effective treatment for patients with metabolic diseases including type 2 diabetes mellitus (T2DM) and obesity. This review focuses on the mechanism of action of liraglutide as a well-known glucagon-like peptide-1 rec...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Diabetes Metab Disord |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer International Publishing
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7843728/ https://ncbi.nlm.nih.gov/pubmed/33520865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40200-020-00619-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|